PA
CVS icon

Prism Advisors’s CVS Health CVS Stock Holding History

Prism Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41,279
Closed -$2.45M – 51
2020
Q1 		$2.45M Buy
41,279
+3,098
+8% +$207K 1.58% 18
2019
Q4 		$2.84M Sell
38,181
-8,832
-19% -$620K 1.44% 17
2019
Q3 		$2.96M Sell
47,013
-678
-1% -$40.2K 1.66% 13
2019
Q2 		$2.6M Buy
47,691
+9,160
+24% +$493K 1.48% 17
2019
Q1 		$2.08M Buy
38,531
+5,320
+16% +$328K 1.19% 25
2018
Q4 		$2.18M Sell
33,211
-1,980
-6% -$148K 1.38% 17
2018
Q3 		$2.56M Sell
35,191
-3,548
-9% -$254K 1.49% 17
2018
Q2 		$2.58M Buy
38,739
+15,017
+63% +$990K 1.37% 21
2018
Q1 		$1.48M Buy
+23,722
New +$1.7M 0.83% 26

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Prism Advisors's CVS Position: Q2 2020 in Review

Prism Advisors sold out of CVS Health (CVS) in Q2 2020, closing a stake of 41,279 shares — an estimated $2.45M sold.

Prism Advisors first reported a position in CVS in Q1 2018 and held it in 9 quarters. The position peaked at $2.96M in Q3 2019. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Prism Advisors reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Prism Advisors sold 41,279 CVS Health shares in Q2 2020, an estimated $2.45M.
  • Prism Advisors first reported a position in CVS Health in Q1 2018 and held it in 9 quarters.
  • Prism Advisors's CVS Health position peaked at $2.96M in Q3 2019.
  • 1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Prism Advisors's 13F filing for Q2 2020, filed 20 Jul 2020.